The complex genetics of hypoplastic left heart syndrome
Related Experiment Video
Updated: Mar 2, 2026

Author Spotlight: Effect of Left Atrial Ligation on Avian Embryonic Hearts and HLHS Implications
Published on: June 16, 2023
Xiaoqin Liu1, Hisato Yagi1, Shazina Saeed1
1Department of Developmental Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Insights
Hypoplastic left heart syndrome (HLHS), a severe congenital heart defect (CHD), is genetically complex. This study identifies novel digenic gene combinations, like Sap130 and Pcdha9, causing HLHS, offering a new genetic paradigm.
Area of Science:
- Genetics
- Developmental Biology
- Cardiology
Background:
- Congenital heart disease (CHD) affects approximately 1% of newborns, with a complex genetic basis.
- The genetic etiology of severe CHD, such as hypoplastic left heart syndrome (HLHS), remains largely undefined.
- Sporadic occurrences suggest intricate genetic factors beyond simple inheritance patterns.
Purpose of the Study:
- To identify the genetic causes of hypoplastic left heart syndrome (HLHS).
- To investigate the multigenic and genetically heterogeneous nature of HLHS.
- To establish a new paradigm for understanding the complex genetics of CHD.
Main Methods:
- Utilized mouse forward genetics to isolate HLHS mutant mouse lines.
- Employed CRISPR-Cas9 genome editing for gene validation in mice.
- Developed mouse and zebrafish models to study gene function in HLHS pathogenesis.
Main Results:
- Identified mutations in Sap130 and Pcdha9 as digenic causes of HLHS.
- Found multigenic enrichment in human chromosomal regions associated with HLHS.
- Observed Sap130 mediating left ventricular hypoplasia and Pcdha9 increasing aortic valve abnormalities in HLHS models.
Conclusions:
- HLHS is a multigenic and genetically heterogeneous condition.
- Novel genes, Sap130 and Pcdha9, contribute to HLHS development.
- HLHS can result from combinatorial genetic interactions, advancing the understanding of CHD genetics.
Abstract:
Congenital heart disease (CHD) affects up to 1% of live births. Although a genetic etiology is indicated by an increased recurrence risk, sporadic occurrence suggests that CHD genetics is complex. Here, we show that hypoplastic left heart syndrome (HLHS), a severe CHD, is multigenic and genetically heterogeneous. Using mouse forward genetics, we report what is, to our knowledge, the first isolation of HLHS mutant mice and identification of genes causing HLHS. Mutations from seven HLHS mouse lines showed multigenic enrichment in ten human chromosome regions linked to HLHS. Mutations in Sap130 and Pcdha9, genes not previously associated with CHD, were validated by CRISPR-Cas9 genome editing in mice as being digenic causes of HLHS. We also identified one subject with HLHS with SAP130 and PCDHA13 mutations. Mouse and zebrafish modeling showed that Sap130 mediates left ventricular hypoplasia, whereas Pcdha9 increases penetrance of aortic valve abnormalities, both signature HLHS defects. These findings show that HLHS can arise genetically in a combinatorial fashion, thus providing a new paradigm for the complex genetics of CHD.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Genetic Lingo
Pleiotropy
Sex-linked Disorders
Pathophysiology of Heart Failure

